2. Next, let's look at Haemonetics, which engages in the design, development, manufacture and marketing of automated blood-component collection devices and surgical blood salvage devices in the U.S. and internationally.
Haemonetics traded positive yesterday, and closed up 1.11% to $33.82 per share.
- Monday's range: $33.36 - $33.86
- 52-week range: $29.86 - $45.90
- Monday's volume: 311,108
- 3-month average volume: 648,719
Haemonetics is a rounded bottom breakout, and yesterday shares closed over the 50-day simple moving average. We need to see followthrough today, with continued trading over the 50, and increased investor interest in the form of higher volumes.
This stock has pretty low volume, so it's a bit of a slow mover, but it has continued to rise since reaching its 52-week low on May 1. It formed a bullish engulfing signal at the bottom, and the share price is up 11% since then. 11% in the last 18 days is pretty dang good.There is overhead resistance at the gap down that occurred on March 24, so there is resistance through the whole gap down. The gap down levels are $35.35 to $37.45, so look for the gap to be filled. My first target is the 200-day simple moving average at $38.73, which is 14% to the upside. I'd set a stop just below yesterday's low of $33.36, as I wouldn't want it to trade below this level. stay long until you see a confirmed sell signal, or a close below the t-line. 3. Next, let's look at HMS Holdings, which provides cost-containment services to government and private health care payers and sponsors. The company's services include coordination of benefits and program integrity services. HMS traded positive yesterday, closing up 5.17% to $18.20 per share.
- Monday's range: $17.11 - $18.24
- 52-week range: $15.10 - $26.77
- Monday's volume: 843,897
- 3-month average volume: 1,017,360
"If you don't know who you are, the stock market is an expensive place to find out.">>Read More: Why Can't You Lease a Tesla? >>Read More: Can the New Surface Give Microsoft a Boost? >>Read More: It's Do or Die For the Most Pathetic Retailers At the time of publication, the author held no positions in any of the stocks mentioned. Follow @aarongallaher This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.